Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies

David E. Clark, Bohdan Waszkowycz, Melanie Wong, Peter M. Lockey, Robert Adalbert, Jonathan Gilley, Jonathan Clark, Michael P. Coleman

Research output: Contribution to journalArticlepeer-review

Abstract

NAMPT may represent a novel target for drug discovery in various therapeutic areas, including oncology and inflammation. Additionally, recent work has suggested that targeting NAMPT has potential in treating axon degeneration. In this work, publicly available X-ray co-crystal structures of NAMPT and the structures of two known NAMPT inhibitors were used as the basis for a structure- and ligand-based virtual screening campaign. From this, two novel series of NAMPT inhibitors were identified, one of which showed a statistically significant protective effect when tested in a cellular model of axon degeneration.

Original languageEnglish
Pages (from-to)2920-2926
Number of pages7
JournalBioorganic and Medicinal Chemistry Letters
Volume26
Issue number12
DOIs
Publication statusPublished - 15 Jun 2016

Keywords

  • Axon degeneration
  • Molecular docking
  • NAMPT
  • Similarity searching
  • Virtual screening

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies'. Together they form a unique fingerprint.

Cite this